Press Releases

Press Releases

July 6, 2017
Breakthrough Research Published in PLOS ONE Demonstrates Quantitative, PCR-Free Detection of MicroRNA
CAMBRIDGE, MA – September 30, 2008 – Quanterix Corporation, the leader in single molecule protein detection, announced today that it has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Cancer Institute of the National Institutes of Health (NIH). This grant…
CAMBRIDGE, MA – February 22, 2011 – Quanterix Corporation, enabling a new generation of diagnostic tests based on revolutionary Single Molecule Array (SiMoA™) technology, today announced that it has entered into an evaluation agreement with Novartis Diagnostics on the potential use of Quanterix’s…
CAMBRIDGE, MA – October 13, 2011 – Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, today announced results from a clinical evaluation of its Prostate Specific Antigen (PSA) test, a fifth–…
LEXINGTON, MA – August 7th, 2012 – Quanterix Corporation, developer of the Single Molecule Array (Simoa) technology, announced today that it had been issued a US Patent for ultra-sensitive detection of molecules. The patent issue marks another milestone for Quanterix and highlights the achievements…
Lexington, Mass. – October 16, 2013 – Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it has continued to build its patent portfolio with the issuance of three key patents for…
Lexington, Mass--(BUSINESS WIRE)– June 10, 2014 Quanterix, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the appointment of Kevin Hrusovsky as Executive Chairman of its Board of Directors.
LEXINGTON, MA – March 16, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced it had appointed SCRUM, Inc., of Tokyo, Japan, as an exclusive distributor for sales and support of…
LEXINGTON, MA – August 3, 2015 Quanterix Corporation, a leader in high definition diagnostics, today announced that JAMA Neurology has published a new study in which its Simoa (single molecule array) technology was used to identify a protein previously linked to acute symptoms following a traumatic…
January 11, 2016
Quanterix announces that it will be presenting at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, California.